» Articles » PMID: 23076557

Poor Survival Rate in Patients with Postoperative Intra-abdominal Infectious Complications Following Curative Gastrectomy for Gastric Cancer

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2012 Oct 19
PMID 23076557
Citations 162
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The impact of postoperative complications on recurrence rate and long-term outcome has been reported in patients with colorectal and esophageal cancer, but not in patients with gastric cancer. This study evaluated the impact of postoperative intra-abdominal infectious complications on long-term survival following curative gastrectomy.

Methods: This study included 765 patients who underwent curative gastrectomy for gastric cancer between 2002 and 2006. Patients were divided into 2 groups: with (C-group, n = 81) or without (NC-group, n = 684) intra-abdominal infectious complications. Survival curves were compared between the groups, and multivariate analysis was conducted to identify independent prognostic factors.

Results: Male patients were dominant, and total gastrectomy was frequently performed in the C-group. The pathological stage was more advanced and D2 lymph node dissection and splenectomy were preferred in the C-group. The 5-year overall survival (OS) rate was better in the NC-group (86.8 %) than in the C-group (66.4 %; P < .001). The 5-year relapse-free survival (RFS) rate was also better in the NC-group (84.5 %) than in the C-group (64.9 %; P < .001). This trend was still observed in stage II and III patients after stratification by pathological stage. Multivariate analysis identified intra-abdominal infectious complication as an independent prognostic factor for OS (hazard ratio, 2.448; 95 % confidence interval [95 % CI], 1.475-4.060) and RFS (hazard ratio, 2.219; 95 % CI, 1.330-3.409) in patients with advanced disease.

Conclusions: Postoperative intra-abdominal infectious complications adversely affect OS and RFS. Meticulous surgery is needed to decrease the complication rate and improve the long-term outcome of patients following curative gastrectomy.

Citing Articles

Usefulness of Serum Biomarkers in Predicting Anastomotic Leakage After Gastrectomy.

Ramos D, Gallego-Colon E, Minguez J, Bodega I, Priego P, Garcia-Moreno F Cancers (Basel). 2025; 17(1.

PMID: 39796753 PMC: 11720279. DOI: 10.3390/cancers17010125.


CRP to Albumin Ratio as a Prognostic Nutrition-Based Biomarker for Patients With Gastric Cancer: A Narrative Review.

Christodoulidis G, Voutyras A, Fotakopoulos G, Koumarelas K, Georgakopoulou V, Kouliou M Cureus. 2024; 16(10):e71516.

PMID: 39553069 PMC: 11563776. DOI: 10.7759/cureus.71516.


Impact of infectious complications after gastrectomy on non‑gastric cancer‑related deaths.

Nakashima C, Iida M, Nishiyama M, Watanabe Y, Shindo Y, Tokumitsu Y Oncol Lett. 2024; 28(6):562.

PMID: 39385950 PMC: 11462511. DOI: 10.3892/ol.2024.14695.


The clinical outcome of minor changes in serum creatinine for patients after curative gastrectomy: a prospective study.

Cai W, Zeng X, Huang Y, Chen W, Chen X, Xie X Front Oncol. 2024; 14:1416888.

PMID: 39234398 PMC: 11371684. DOI: 10.3389/fonc.2024.1416888.


Perioperative chemotherapy with nivolumab for HER2-negative locally advanced gastric cancer: a case series.

Toji Y, Takeuchi S, Ebihara Y, Kurashima Y, Harada K, Hayashi M Surg Case Rep. 2024; 10(1):200.

PMID: 39192090 PMC: 11349963. DOI: 10.1186/s40792-024-02001-w.